PMID- 8899677 OWN - NLM STAT- MEDLINE DCOM- 19970519 LR - 20191101 IS - 0958-3947 (Print) IS - 1873-4022 (Linking) VI - 21 IP - 3 DP - 1996 Fall TI - Reduction of the rectal dose in gynecological brachytherapy: modification to the Fletcher-Suit applicator. PG - 139-43 AB - The dose to the anterior rectal wall is a known limiting factor for the delivery of radical doses of radiation to the uterine cervix with brachytherapy. We developed a modification to the Fletcher-Suit afterloading applicator, consisting of two small inflatable balloons attached to the posterior end of each colpostat. The balloons are connected to catheters that emerge from the vagina attached to the colpostat's handles. The balloons were affixed to the colpostats with a plastic adaptor and are inserted empty. After an anterior radiograph is taken, the balloons are filled with radiological contrast material and a lateral orthogonal film is made. This lateral film taken with the balloons filled with contrast typically shows a significant posterior displacement of the anterior rectal wall away from the vaginal sources. The International Commission on Radiation Units (ICRU) rectal point is then determined 5 mm beyond the posterior boundary of the opacified balloons. We have performed 90 applications using this device, including brachytherapy applications for cervical cancer, as well as vaginal applications for endometrial carcinoma following TAH-BSO. On average, the ICRU rectal point was displaced 14 mm away from the colpostats, thus reducing the dose rate by 60% and resulting in an average dose sparing of about 1000 cGy to the anterior rectal wall. FAU - Rosenblatt, E AU - Rosenblatt E AD - Department of Oncology, Rambam Medical Center, Haifa, Israel. FAU - Cederbaum, M AU - Cederbaum M FAU - Yereslav, N AU - Yereslav N FAU - Kuten, A AU - Kuten A LA - eng PT - Journal Article PL - United States TA - Med Dosim JT - Medical dosimetry : official journal of the American Association of Medical Dosimetrists JID - 8908862 RN - 0 (Contrast Media) RN - 3X9MR4N98U (Diatrizoate Meglumine) SB - IM MH - Brachytherapy/*instrumentation MH - Carcinoma/radiotherapy MH - Catheterization/instrumentation MH - Contrast Media MH - Diatrizoate Meglumine MH - Endometrial Neoplasms/radiotherapy MH - Equipment Design MH - Female MH - Humans MH - Radiography MH - *Radiotherapy Dosage MH - Rectum/diagnostic imaging/*radiation effects MH - Uterine Cervical Neoplasms/*radiotherapy EDAT- 1996/10/01 00:00 MHDA- 1996/10/01 00:01 CRDT- 1996/10/01 00:00 PHST- 1996/10/01 00:00 [pubmed] PHST- 1996/10/01 00:01 [medline] PHST- 1996/10/01 00:00 [entrez] AID - 0958-3947(96)00079-9 [pii] AID - 10.1016/0958-3947(96)00079-9 [doi] PST - ppublish SO - Med Dosim. 1996 Fall;21(3):139-43. doi: 10.1016/0958-3947(96)00079-9.